These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1997862)

  • 1. Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP.
    Stasior DS; Kikeri D; Duel B; Seifter JL
    N Engl J Med; 1991 Mar; 324(12):850-1. PubMed ID: 1997862
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate.
    Weinstock RS; Moses AM
    South Med J; 1990 Dec; 83(12):1475-7. PubMed ID: 2123565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal response of factor VIII and von Willebrand factor to 1-deamino-8D-arginine vasopressin in nephrogenic diabetes insipidus.
    Brenner B; Seligsohn U; Hochberg Z
    J Clin Endocrinol Metab; 1988 Jul; 67(1):191-3. PubMed ID: 3132483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked hypotonic polyuria resulting from nephrogenic diabetes insipidus with partial sensitivity to vasopressin.
    Moses AM; Scheinman SJ; Oppenheim A
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1044-9. PubMed ID: 6490792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
    Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
    N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of diabetes insipidus with DDAVP.
    Lampert RP; Blackett PR; Rennert OM
    J Pediatr; 1978 Nov; 93(5):896-7. PubMed ID: 712511
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic reaction to DDAVP in diabetes insipidus: successful treatment with its graded doses.
    Yokota M; Matsukura S; Kaji H; Taminato T; Fujita T
    Endocrinol Jpn; 1982 Aug; 29(4):475-7. PubMed ID: 6217968
    [No Abstract]   [Full Text] [Related]  

  • 9. DDAVP in the treatment of central diabetes insipidus.
    Robinson AG
    N Engl J Med; 1976 Mar; 294(10):507-11. PubMed ID: 1250255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with DDAVP (1-deamino-8-D-arginine vasopressin), a new synthetic analog of vasopressin, in the treatment of childhood diabetes insipidus].
    Lebacq E; David L
    Pediatrie; 1975; 30(3):265-270. PubMed ID: 1178251
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pseudoresistance to DDAVP in diabetes insipidus].
    Radó J; Pató E; Czigner J; Fáber K
    Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetes insipidus--with special reference to DDAVP therapy].
    Shimizu K
    Nihon Rinsho; 1979; 37(4):849-55. PubMed ID: 449070
    [No Abstract]   [Full Text] [Related]  

  • 14. Ten-year experience with DDAVP in treatment of diabetes insipidus.
    Marek J; Loutocký A; Pacovský V; Zaoral M
    Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is testing with dDAVP useful in detecting carriers of the nephrogenic diabetes insipidus gene?
    Bichet DG; Arthus MF; Lonergan M
    Nephron; 1991; 58(3):372-3. PubMed ID: 1896107
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of DDAVP (1-desamino-8-D-arginine vasopressin) in children with central diabetes insipidus (author's transl)].
    Tomita M; Nakagawa S; Saito N; Sakurada N; Nonoda A
    Horumon To Rinsho; 1979 Jun; 27(6):681-5. PubMed ID: 466837
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of central diabetes insipidus with DDAVP.
    Chiu WT; Shih CJ; Chen HY; Lin LS
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):944-52. PubMed ID: 3865998
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of 2 new formulations of desmopressin (DDAVP), nasal spray and tablets, in the therapy of diabetes insipidus].
    Gelli D; Riolo A; Carioni E; Albano M
    Minerva Endocrinol; 1989; 14(4):227-32. PubMed ID: 2636699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal prostaglandin E2 in nephrogenic diabetes insipidus: effects of inhibition of prostaglandin synthesis by indomethacin.
    Usberti M; Dechaux M; Guillot M; Seligmann R; Pavlovitch H; Loirat C; Sachs C; Broyer M
    J Pediatr; 1980 Sep; 97(3):476-8. PubMed ID: 6251193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.